Page 14 - Alkermes News Today

Pharmaceutical company Alkermes has announced the sale of its research, development and manufacturing plant in County Roscommon to a Danish multinational healthcare company for $92.5m.

/PRNewswire/ -- The "Antipsychotic Drugs Market Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.coms offering. With mental health...

Danish weight loss and diabetes specialist is looking to develop a tablet form of its blockbuster obesity treatments

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it has entered into a definitive agreement to sell its development and manufacturing facility...

Alkermes announced that it has entered into a definitive agreement to sell its development and manufacturing facility in Athlone, Ireland to Novo Nordisk.

(RTTNews) - Alkermes plc (ALKS) has entered into a definitive agreement to sell its development and manufacturing facility in Athlone, Ireland to ...

Alkermes Culture of Employee Engagement and Wellness

Novo Nordisk has become one of Europe’s most valuable companies due to their weight-loss drugs.

Novo Nordisk has become one of Europe’s most valuable companies due to their weight-loss drugs.

Agreement over Elan Drug Technologies plant is expected to close mid-2024